| 
 | Compound Information | SONAR Target prediction |  | Name: | CHOLESTEROL |  | Unique Identifier: | SPE01500847 |  | MolClass: | Checkout models in ver1.5 and ver1.0 |  | Molecular Formula: |  |  | Molecular Weight: | 340.288 g/mol |  | X log p: | 3.038  (online calculus) |  | Lipinksi Failures | 0 |  | TPSA | 0 |  | Hydrogen Bond Donor Count: | 0 |  | Hydrogen Bond Acceptors Count: | 1 |  | Rotatable Bond Count: | 5 |  | Canonical Smiles: | CC(C)CCCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C |  | Class: | sterol |  | Source: | common animal sterol |  | Generic_name: | CHOLESTEROL |  | Chemical_iupac_name: | CHOLESTEROL |  | Drug_type: | Experimental |  | Kegg_compound_id: | C00187 |  | Drugbank_id: | EXPT00945 |  | Logp: | 7.445 |  | Cas_registry_number: | 57-88-5 |  | Drug_category: | Nuclear Receptor Ror-Alpha inhibitor |  | Organisms_affected: | -1 | 
 
 
	
		| Species: | 4932 |  
		| Condition: | AAT2 |  
		| Replicates: | 2 |  
		| Raw OD Value: r im | 0.7171±0.0000707107 |  
		| Normalized OD Score: sc h | 0.9814±0.00286496 |  
		| Z-Score: | -0.9870±0.130177 |  
		| p-Value: | 0.325708 |  
		| Z-Factor: | -2.16064 |  
		| Fitness Defect: | 1.1218 |  
		| Bioactivity Statement: | Nonactive |  | | Experimental Conditions |  |  | Library: | SPECMTS3 |  | Plate Number and Position: | 16|A10 |  | Drug Concentration: | 50.00 nM |  | OD Absorbance: | 600 nm |  | Robot Temperature: | 24.80 Celcius |  | Date: | 2008-04-08 YYYY-MM-DD |  | Plate CH Control (+): | 0.040475±0.00119 |  | Plate DMSO Control (-): | 0.70815±0.01282 |  | Plate Z-Factor: | 0.9284 | 
 |  png ps
 pdf
 | 
 
 
	
		| 3035603 | 17-[4-(2,2-dimethylcyclopropyl)butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-c yclopenta[a]phenanthren-3-ol
 |  
		| 3036774 | (3S,8S,9S,10R,13S,14S,17E)-10,13-dimethyl-17-[(4R,5R)-4,5,6-trimethylheptan-2-ylidene]-1,2,3,4,7,8,9,11, 12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-ol
 |  
		| 3037906 | (3S,8S,9S,10R,13S,14S,17E)-17-[(4R,5S)-6-hydroxy-4,5,6-trimethyl-heptan-2-ylidene]-10,13-dimethyl-1,2,3, 4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-ol
 |  
		| 3082174 | (3S,8S,9S,10R,13R,14S,17S)-17-(2-hydroxypropan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodeca hydro-1H-cyclopenta[a]phenanthren-3-ol
 |  
		| 3082711 | (3S,8R,9S,10R,13R,17R)-10,13,14-trimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,7,8,9,11,12,15,16,17-dod ecahydrocyclopenta[a]phenanthren-3-ol
 |  
		| 3083182 | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-1-[(1R,2R,3S)-2-methyl-3-propan-2-yl-cyclopropyl]prop an-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
 |  
 | internal high similarity DBLink  | Rows returned: 8 | 1 2 Next >> | 
 
 | active | Cluster 17506 | Additional Members: 20 | Rows returned: 4 |  | 
 
 |